US Stock MarketDetailed Quotes
CALA Calithera Biosciences
- 0.020000
- 0.0000000.00%
15min DelayClose Apr 26 16:00 ET
97.45KMarket Cap-2P/E (TTM)
0.020000High0.020000Low261Volume0.020000Open0.020000Pre Close5.22Turnover0.01%Turnover RatioLossP/E (Static)4.87MShares0.49990052wk High-0.05P/B96.39KFloat Cap0.01000052wk Low--Dividend TTM4.82MShs Float669.600000Historical High--Div YieldTTM0.00%Amplitude0.010000Historical Low0.020000Avg Price1Lot Size
Calithera Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 34.23%-43.61M | 66.38%-8.6M | -1.72%-7.74M | -1.29%-11.26M | 27.23%-16.01M | 21.36%-66.3M | -11.18%-25.57M | 53.35%-7.61M | 38.20%-11.12M | 18.56%-22M |
| Net income from continuing operations | 65.55%-39.65M | 89.98%-6.94M | 12.26%-9.8M | 36.57%-9.08M | 32.16%-13.84M | -27.68%-115.09M | -206.70%-69.21M | 50.86%-11.17M | 29.82%-14.31M | 16.57%-20.4M |
| Operating gains losses | ---1.95M | ---169K | --453K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -8.93%255K | 0.00%65K | -10.14%62K | -12.33%64K | -12.33%64K | -23.08%280K | -20.73%65K | -19.77%69K | -19.78%73K | -30.48%73K |
| Other non cash items | -97.29%1.13M | -99.29%292K | 9.58%286K | 9.41%279K | 2,581.82%273K | 2,665.41%41.65M | 10,449.23%41.14M | -31.68%261K | -31.45%255K | -103.04%-11K |
| Change In working capital | -118.09%-7.43M | -3,456.63%-2.79M | -50.61%326K | -681.74%-1.27M | 15.46%-3.69M | 14.08%-3.41M | 102.95%83K | -82.85%660K | 477.59%219K | 11.67%-4.37M |
| -Change in receivables | --0 | --0 | --0 | -87.50%127K | -124.76%-127K | 245.51%1.54M | 101.12%12K | --0 | 1,816.98%1.02M | 203.85%513K |
| -Change in prepaid assets | 672.92%742K | -532.56%-544K | 788.14%406K | 19.30%1.03M | 76.41%-146K | 265.52%96K | 64.46%-86K | 78.39%-59K | 280.53%860K | -367.97%-619K |
| -Change in payables and accrued expense | -75.69%-6.79M | -495.18%-1.89M | -73.04%265K | -36.03%-2.09M | 18.62%-3.09M | -134.65%-3.87M | 134.07%477K | -72.95%983K | -1,400.85%-1.54M | 5.20%-3.79M |
| -Change in other current assets | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Change in other current liabilities | -16.94%-1.37M | -11.56%-357K | -11.29%-345K | -346.05%-339K | 29.00%-333K | 20.50%-1.18M | 26.61%-320K | -36.56%-310K | 81.55%-76K | -16.38%-469K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 34.23%-43.61M | 66.38%-8.6M | -1.72%-7.74M | -1.29%-11.26M | 27.23%-16.01M | 21.36%-66.3M | -11.18%-25.57M | 53.35%-7.61M | 38.20%-11.12M | 18.56%-22M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -101.69%-133K | 41.03%-23K | 0 | -107.33%-110K | 0 | -91.17%7.85M | -100.43%-39K | -100.49%-108K | -97.44%1.5M | 1,158.63%6.5M |
| Net PPE purchase and sale | 9.52%-133K | 41.03%-23K | --0 | ---- | ---- | -140.98%-147K | -8.33%-39K | -800.00%-108K | ---- | ---- |
| Net investment purchase and sale | --0 | --0 | --0 | --0 | --0 | -91.01%8M | --0 | --0 | -97.44%1.5M | 1,181.53%6.5M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -101.69%-133K | 41.03%-23K | --0 | -107.33%-110K | --0 | -91.17%7.85M | -100.43%-39K | -100.49%-108K | -97.44%1.5M | 1,158.63%6.5M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -9.50%9.66M | -99.39%4K | 1,400.00%15K | 1,689.26%8.5M | -88.08%1.14M | -74.64%10.67M | 31.00%655K | -50.00%1K | -98.60%475K | 24.52%9.54M |
| Net common stock issuance | -9.61%9.64M | --0 | --15K | 2,304.25%8.49M | -88.08%1.14M | -73.90%10.66M | --776K | --0 | -98.95%353K | 28.90%9.54M |
| Proceeds from stock option exercised by employees | -90.96%16K | -92.31%4K | --0 | -90.16%12K | --0 | -85.25%177K | -89.60%52K | --1K | -72.15%122K | -99.24%2K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---173K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -9.50%9.66M | -99.39%4K | 1,400.00%15K | 1,689.26%8.5M | -88.08%1.14M | -74.64%10.67M | 31.00%655K | -50.00%1K | -98.60%475K | 24.52%9.54M |
| Net cash flow | ||||||||||
| Beginning cash position | -44.41%59.81M | -59.49%34.34M | -54.52%42.06M | -55.78%44.93M | -44.41%59.81M | 76.73%107.59M | -29.96%84.76M | -19.82%92.48M | 148.42%101.62M | 76.73%107.59M |
| Current changes in cash | 28.66%-34.09M | 65.47%-8.62M | -0.12%-7.72M | 68.57%-2.88M | -149.34%-14.87M | -202.29%-47.78M | -85.74%-24.96M | -235.61%-7.71M | -112.29%-9.15M | 70.13%-5.97M |
| End cash Position | -56.99%25.72M | -56.99%25.72M | -59.49%34.34M | -54.52%42.06M | -55.78%44.93M | -44.41%59.81M | -44.41%59.81M | -29.96%84.76M | -19.82%92.48M | 148.42%101.62M |
| Free cash flow | 34.17%-43.74M | 66.34%-8.62M | -0.30%-7.74M | -2.27%-11.37M | 27.23%-16.01M | 21.25%-66.45M | -11.17%-25.61M | 52.72%-7.71M | 38.20%-11.12M | 18.60%-22M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg